Download our handy infographic for using Swift Normalase™ Amplicon SARS-CoV-2 Panel (SNAP) technology for the targeted sequencing of SARS-CoV-2 variants, and discover what insights it can uncover.
The Swift Normalase™ Amplicon SARS-CoV-2 NGS Panel (SNAP) technology offers optimized next-generation sequencing for SARS-CoV-2, and enables identification of SARS-CoV-2 variants from a variety of samples. The panel utilizes multiple overlapping amplicons in a single tube, using a rapid, 2-hour workflow to prepare ready-to-sequence libraries. Overlapping primers ensure that known and emerging variants are detected - for tracking nucleotide variants and improve understanding of virus evolution, transmission, and pathogenesis. Furthermore, targeted pathogen sequencing can enable variant detection in S Gene dropouts in COVID-19 samples.
Download the infographic to discover:
- A guide to the Swift Normalase™ Amplicon Panels (SNAP) workflow
- How SNAP primers cover 99.7% of the genome to ensure you capture new and emerging variants
- How SNAP can save you money and time in order to scale large studies
For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.